Immunology Flashcards
Q: What are the 5 antigen presenting cells of the body [?]
- Monocyte
- Macrophage
- Dendritic cell
- Langerhans cell
- B-cell
- Also, Microglia (brain) and Kupfer cells (liver)
Q: Discuss cell-mediated immunity [?]
- Type of adaptive cell immunity
- Major Histocompatibility Complex proteins:
Class I – present on all nucleated cells, binds to CD8+
Class II – present on APC’s, bind to CD4+ - - T-cell subclasses:
1-Helper cells (TH) – Express CD4+, recognizes class II MHC’s (signal 1) and requires CD28 activation (signal 2) = secretes IL2 (autocrine-based proliferation); 2 subsets:
TH1 (cell mediated) stimulates IgM, IgG and IgA macrophages CD8+ T cell activation & increases CMI response,
TH2 (humoral); activate B cells (IgE > IgG)
2- Cytotoxic (TC) – Express CD8+, recognizes antigen expressed with Class I MHC
3- Suppressor (TS)
Q: Discuss humoral immunity [?]
- B-cells bear surface receptors (Fc) similar to Ig’s
- T-dependent activation: Antigen is bound, processed and expressed on MHC II; primed CD4 TH2-cell (turned on from same Ag from different cell) binds to B-cell CD40, which causes cell proliferation and plasma cell differentiation
- T-independent activation – strong Ags (bacterial capsule / cell wall); Inefficient, provides mainly IgM
Q: Discuss Immunoglobulins: Structure; subtypes [?]
- Structure – 2 Light chains (2 types = kappa & lambda), 2 Heavy chains (5 types, determine class of antibody= M, A, G, E, D)
- IgM – Predominates in early immune response; Pentameric, IgM & IgD main Ig’s expressed on B-cell surface
- IgA – Predominates in bodily secretions; primary defense against local mucosal infection, dimeric with a secretory component bound to it
- IgG – 75% of total serum antibodies; 4 subtypes, crosses placenta to protect fetus, can fix complement - IgE – Binds to mast cells & basophils, triggers inflammatory mediator release
- IgD – Found in serum; monomeric, main function unknown
Q: Discuss Complement: Activation pathways (2), 4 activities [?]
- Primary humoral mediator of antigen-antibody reactions
- 2 Activation Pathways:
Classical (activated by IgG/IgM, C1 –> C4b,2b)
Alternative (PAMPs (pathogen associated molecular patterns), C3 –> C3b,Bb) - 4 Biologic activities (COAL)
Chemotaxis
Opsonization,
Cell Activation (neutrophils & macrophages)
Cell Lysis through the membrane attack complex (MAC)
Q: Describe the allergic reaction at the cellular level [?]
- Early response (~5 minutes post-exposure) – mediated by Mast cells & Basophils; IgE binds to FceR on mast cell, crosslinking of IgE triggers activation = Degranulation of mast cell’s preformed mediators (histamine, heparin, tryptase, beta-glucosaminidase, eosinophil & neutrophil chemotactic factors), and Synthesis of mediators from membrane bound phospholipids (PGs, LTs, PAF)
- Late response (~4 hours post exposure) – mediated by neutrophils & eosinophils, reaction secondary to cytokines
Q: Describe 3 phases of allergic rhinitis [?]
- Acute – due to Histamine and other preformed/newly synthesized mediators; causes sneezing, itchy eyes, nose and throat, nasal discharge
- Intermediate or transitional – due to recruitment and activation of leukocytes into nasal tissue, asymptomatic
- Late phase – 4-6 hours post exposure, due to leukocytes in nasal tissue; main symptom is nasal congestion
Q: Gell and Coombs Type Hypersensitivity Reactions (ACID) [?]
- Type I – Allergy (immediate); TH2 / IgE (Allergic rhinitis, anaphylaxis, asthma)
- Type II – Cytotoxic, Ab-dependent; TH1 / Cytotoxic IgG or IgM antibody mediated (goodpasture)
- Type III – Immune complex mediated, Ag-Ab-Complement (serum sickness, Arthus reaction)
- Type IV – Delayed type hypersensitivity, T-cell mediated CD8+ (TB test, contact dermatis)
- Type V – Receptor-stimulating Ig (Pasha)
Q: Four cellular effects of histamine [?]
- Vasodilation
- Increases capillary permeability
- Bronchoconstriction
- Tissue edema
- Main mediator of early allergic reaction
Q: Five proteins found in eosinophils [?]
- Major basic protein (MBP)
- Eosinophil cationic protein (ECP)
- Eosinophil peroxidase (EPO)
- Charcot Leyden crystal
- Neurotoxin
Q : Discuss HIV: diagnostic tests, clinical categories (including definition of AIDS) [?]
- Acquired immunodeficiency syndrome
- Family retroviridae (subfamily = lentivirus) - Strong disease correlation with CD4 counts
- Three clinical categories
A – Asymptomatic, PGL, or Acute HIV infection
B – Symptomatic condition attributable to HIV infection and associated defects in CMI, but not in A or C
C – AIDS (diagnosis = CD4+ <200 cells/uL, or HIV+ with AIDS defining disease (H&N: NHL, Kaposi, Candidiasis, oral HSV, Mycobacterium, PC, TB) - Stratification by CD4 counts - >500 cells/uL, 200-499 cells/uL, <200 cells/uL
- H&N Manifestations: Oralcavity/oropharynx (oral candidiasis) > cervical LAD > rhinosinusitis >
CSOM
Q (DO): Definition of AIDS?
CD4+ < 200 cell/uL + AIDS defining disease
AIDS defining disease?
1. Candidiasis of bronchi, trachea, or lungs
2. Candidiasis esophagea
3. Coccidioidomycosis, disseminated or extrapulmonary
4. Cryptococcosis, extrapulmonary
5. Cryptosporidiosis, chronic intestinal for longer than 1 month
6. Cytomegalovirus disease (other than liver, spleen or lymph nodes)
7. Cytomegalovirus retinitis (with loss of vision)
8. Encephalopathy (HIV-related)
9. Herpes simplex: chronic ulcer(s) (for more than 1 month); or bronchitis, pneumonitis, or
esophagitis
10. Histoplasmosis, disseminated or extrapulmonary
11. Isosporiasis, chronic intestinal (for more than 1 month)
12. Kaposi’s sarcoma
13. Lymphoma, Burkitt’s
14. Lymphoma, immunoblastic (or equivalent term)
15. Lymphoma, primary, of brain
16. Mycobacterium avium complex or Mycobacterium kansasii, disseminated or
extrapulmonary
17. Mycobacterium, other species, disseminated or extrapulmonary
18. Mycobacterium tuberculosis, any site (extrapulmonary)
19. Pneumocystis jirovecii pneumonia (formerly Pneumocystis carinii)
20. Progressive multifocal leukoencephalopathy
21. Salmonella septicemia (recurrent)
22. Toxoplasmosis of the brain
23. Tuberculosis, disseminated
24. Wasting syndrome due to HIV
Q: Pathologies associated with low CD4 counts and prophylaxis [?]
- <400 cells/uL = TB
- <200 cells/uL = NHL (including sinonasal), PCP – Septra
- <150 cells/uL = Fungal sinusitis
- <100 cells/uL = Kaposi sarcoma, Cryptococcal meningitis, Toxoplasmosis
- <50 cells/uL = Aspergillus, Cryptosporidiosis, CMV, Mycobacterium – Azithromycin - Hodgkin’s is associated with a wide range of CD4
Q: Eight Indications for open biopsy of lymphadenopathy in HIV [?]
1- FNA that suggests Malignancy
2- FNA negative for malignancy with any of: [
- Enlarging node
- Nodes >2cm
- Asymmetric, localized, unilateral adenopathy
- Significant mediastinal or abdominal lymphadenopathy
- Failed antibiotic trial
- Low CD4 with new lymphadenopathy
- B symptoms – Fever, night sweats, weight loss
Q: Ddx of cervical disease in HIV; most common [?]
- Persistent generalized lymphadenopathy (PGL, 12-45%)
- Mycobacterium tuberculosis
- Pneumocystis (carnii)jirovecii pneumonia (PCP)
- Lymphoma
- Kaposi sarcoma (Human Herpes Virus 8)
Q: DDx of skin manifestations of HIV (6) [?]
- Molluscum contagiosum (watery warts; caused by MCV)
- Bacillary angiomatosis (found in immunicompromised pts wth Bartonella Henselae infection) - KS
- HSV
- Herpes Zoster
- Cryptococcus
Four Indications for Treatment of Localized Kaposi sarcoma [?]
KS = HHV-8
- Cosmesis
- Reduction of symptom
- Improved local control
- ?Functional compromise?
Q: Five Treatment modalities for small localized Kaposi sarcomas [?]
CONSERVATIVE
- Observe/do nothing
MEDICAL
- Radiation (only if localized obstruction)
- Chemotherapy: interferon, vinblastine (impair mitotic spindle)
- Topical immunomodulators
- Topical retinoic acid
SURGICAL
- Laser excision
- Cryotherapy
- Surgical excision (cosemesis, functional compromise, local control, reduction of symptoms)
Q: Three Indications for Treatment of Systemic Kaposi sarcoma [?]
- Visceral disease
- Pulmonary disease
- Extensive mucocutaneous involvement (>10 new in 1 month)
Q: Treatment options for Systemic Kaposi sarcoma [?]
HAART (as per emedicine)
- Liposomal Doxo- or Daunorubicin +/- Combination Vinblastine-Bleomycin
- Systemic Etoposide and Paclitaxel
-Q: Oral hairy leukoplakia: Cause, chance of AIDS, 4 other oral findings in AIDS [?]
Due to EBV (herpes family) infection
- Chance of HIV - AIDS: 50% at 15mos, 80% at 30mos, 100% at 60mos
- White, vertically corrugated asymptomatic lesion on anterolateral tongue
- Oral Findings in HIV/AIDs:
- Fungsl: candidiasis, crptococcus, histoplasmosis
- VIRAL: CMV, VZV HSV, HPV
- Neoplastic: Kaposi sarcoma, lymphoma
Q: Describe this condition [?]
black hairy tongue , aka Lingual Villosa Nigra
- Occurs on the anterior surface of the tongue, anterior to circumvillate papillae
- RF: (i) smoking, (ii) poor oral hygiene (iii) xerostomia, (iv) soft diet
- Histology: elongation of filliform papillae, hyperkeratosis, bacteria
- Rx: good oral hygiene, add roughage to diet, +/- keratolytics or anti-fungals; surgical
debridement (laser, electrodesiccation, cold steel) if other options fail
Q: Discuss MS: Clinical, Charcot’s triad, Diagnosis, 4 types, & Treatment [?]
- Immune mediated inflammatory disease attacking myelin of CNS in young adults
- DDx: ALS, MG, HIV encephalopathy, Lyme disease, TIA/RIND/CVA
- Dx:
- Labs: autoimmune workup, FTA-Abs, lyme dz, CBC, ESR, CRP
- Imaging: MRI (demyelined foci in white matter), Evoked potentials, LP = elevated protein/glucose/IgG
*Charcot’s triad – nystagmus, scanning speech, intention tremor
Subtypes: (1) primary progressive, (2) secondary progressive, (3) relapsing-remitting, (4) progressive-relapsing
*Rx: Acute = steroids, plasma exchange (plasmapharesis)/ Chronic - disease modifying agents for MS (interferon-beta, peginterferon-beta, natalizumab)
Q: Discuss Myasthenia Gravis: DDx; Pathophysiology, Causes, Dx, Treatment [?]
Autoimmune disease against the Ach nicotinic postsynaptic receptors of the NMJ
- DDx: MS, ALS (EOMs preserved!), basilar artery thrombosis, Lambert-Eaton (Abs against presynaptic Ca Channels releasing ACh, can be associated with lung cancer, better with repetition)
- Diagnosis – History, Tensilon test (edrophonium = short active AchE inhibitor), 85% positive anti-AChR Ab, Anti-MuSK, anti lipoprotein related, anti-agvin, anti-striational, EMG (repetitive stimulation test, single fiber EMG)
- Types – MGFA Class I (only ocular) to Class V (intubated)
- Treatment – Thymectomy, Acetylcholinesterase inhibitors – Edrophonium (Tensilon), Neostygmine, Pyridostigmine (Mestinon), IVIG, plasmapheresis
- Triggers of exacerbation: surgery, immunizations, infection, extreme sunlight, menstruation, drugs (Ag, Lithium, beta-blockers)